Previously available in Europe, Canada and Japan, the system has received 510(k) clearance from the US Food and Drug Administration.

Royal Philips Electronics claims by digitizing the signal directly in the RF receive coil nearest to the patient and transferring and processing the signal in digital form throughout the imaging chain, Ingenia is able to generate up to a 40% improvement in signal-to-noise ratio compared to previous generation systems.

This facilitates the delivery of crisp image clarity to help clinicians make informed decisions for a wide range of clinical procedures, including traditional applications like neuro and musculoskeletal and fast-growing applications like body and cardiac.

Ingenia’s digital capabilities also overcome the RF channel scalability limitations typical of analog based systems, giving hospitals the flexibility they need to stay on the clinical cutting edge, now and in the future, without expensive hardware upgrades.

With an integrated, hidden posterior coil, the 70cm bore system enables whole upper body imaging in just two stations and coverage for total body without manipulation of the patient or coil, the company said.

These and other features allow users to spend less time on the logistics related to patient set-up, contributing to as much as a 30% increase in throughput compared to previous generation systems.

The wide bore combined with the large field of view allows for a variety of procedures and the scanning of a variety of patients.